secwatch.observer — SEC 8-K summary
======================================

Issuer:     Akari Therapeutics Plc (AKTX)
CIK:        0001541157
Form:       8-K
Filed at:   2024-09-06T23:59:59+00:00
Accession:  0000950170-24-104428
Event type: other_material
Sentiment:  neutral
Materiality: 0.00
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

No material event disclosed; 8-K contains only XBRL context references
----------------------------------------------------------------------

- Filing reports Items 8.01 and 9.01 but provides no narrative or financial data.
- No press release, earnings, or other material event attached.
- Unable to extract any specific facts, numbers, or names from the provided text.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1541157/000095017024104428/0000950170-24-104428-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1541157/000095017024104428/aktx-20240906.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-104428

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer